Black Diamond Therapeutics Inc logo

BDTX - Black Diamond Therapeutics Inc News Story

$26.11 1.8  7.3%

Last Trade - 21/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £630.9m
Enterprise Value £404.8m
Revenue £n/a
Position in Universe 2928th / 6852

BRIEF-Black Diamond Therapeutics Posts Q2 Loss Per Share Of 41 Cents

Tue 11th August, 2020 1:16pm
Aug 11 (Reuters) - Black Diamond Therapeutics Inc  BDTX.O :
    * BLACK DIAMOND THERAPEUTICS REPORTS SECOND QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * BLACK DIAMOND THERAPEUTICS INC QTRLY LOSS PER SHARE 41
CENTS
    * BLACK DIAMOND THERAPEUTICS INC - CASH, CASH EQUIVALENTS,
AND
INVESTMENTS AS OF JUNE 30,  BELIEVED TO BE SUFFICIENT TO FUND
OPERATIONS INTO 2023

Source text for Eikon:  ID:nGNX31RlQd 
Further company coverage:  BDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.